Editor's Note A new study from the Centers for Disease Control and Prevention (CDC) finds that more than 83% of Americans had COVID-19 antibodies before the surge of the Delta variant began. Researchers examined data from 1,443,519 blood donation specimens obtained before the Delta variant. Overall infection-induced COVID-19 antibodies increased…
Editor's Note An Axios-Ipsos poll published August 31 finds that COVID-19 vaccine hesitancy may be waning. Among the findings: 20% are not likely at all or not very likely to receive a COVID-19 vaccine, down from 23% 2 weeks ago and 34% in March 68% with K-12 children have either…
Editors Note The Food and Drug Administration (FDA) on August 23 identified the recall by Cardinal Health of its Monoject Saline Flush Prefilled Syringes as Class I, the most serious. Cardinal Health is recalling three models of the syringes because the syringe plunger may pull air into the syringe after…
Editor's Note On August 23, the American Nurses Association (ANA), American Medical Association (AMA), and American Hospital Association (AHA) released a joint statement commending the Food and Drug Administration’s (FDA’s) full approval of the Pfizer-BioNTech COVID-19 vaccine. The approval marks an important moment for those concerned about getting vaccinated because…
Editor's Note The Food and Drug Administration on August 23 announced that it had approved the first COVID-19 vaccine, known as Pfizer-BioNTech. The vaccine will now be marketed as Comirnaty, for the prevention of COVID-19 in those 16 years of age and older. The vaccine will continue to be available…
Editor's Note Data from a new survey of more than 4,500 nurses conducted by the American Nurses Association (ANA) in conjunction with the Johnson & Johnson-sponsored “COVID Vaccine Facts for Nurses” campaign finds that about 90% are vaccinated against COVID-19 or plan to be vaccinated. Other findings from the survey…
Editor's Note In this study by Mayo Clinic researchers, two monoclonal antibodies administered separately helped prevent hospitalization in high-risk COVID-19 patients. Included in the analysis were 2,747 patients who received bamlanivimab and 849 patients who received casirivimab-imdevimab from November 19, 2020, to February 11, 2021. After 28 days, all cause…
Editor's Note The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) issued a joint statement on July 8 saying that fully vaccinated Americans do not need COVID-19 booster shots at this time. The statement says the CDC, FDA, and National Institutes of Health are engaged…
Editor's Note The Food and Drug Administration (FDA) on July 2 identified the recall by Medtronic Vascular of its angiographic guidewire component as Class I, the most serious. The recall was initiated because the devices were not sterilized before being shipped to hospitals. The guidewire is used during angiography or other interventional…
Editor's Note The Food and Drug Administration (FDA) on June 30 announced that it is revoking the Emergency Use Authorizations (EUAs) for non-NIOSH-approved disposable respirators (including N95s), effective July 6. The announcement also revokes EUAs for decontamination and bioburden reduction systems for disposable respirators, effective immediately. The FDA says the…